Skip to main content

Peer Review reports

From: A phase I study of a dual PI3-kinase/mTOR inhibitor BEZ235 in adult patients with relapsed or refractory acute leukemia

Original Submission
8 Jan 2020 Submitted Original manuscript
5 Jun 2020 Reviewed Reviewer Report
30 Jun 2020 Reviewed Reviewer Report - Jordi Ribera
19 Jul 2020 Author responded Author comments - Fabian Lang
Resubmission - Version 2
19 Jul 2020 Submitted Manuscript version 2
1 Sep 2020 Author responded Author comments - Fabian Lang
Resubmission - Version 3
1 Sep 2020 Submitted Manuscript version 3
3 Sep 2020 Author responded Author comments - Fabian Lang
Resubmission - Version 4
3 Sep 2020 Submitted Manuscript version 4
Publishing
6 Sep 2020 Editorially accepted
29 Sep 2020 Article published 10.1186/s40360-020-00446-x

You can find further information about peer review here.

Back to article page